메뉴 건너뛰기




Volumn 7, Issue 11, 2016, Pages 13060-13068

Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma

Author keywords

CD28; CTLA 4; Immunohistochemistry; Nasopharyngeal carcinoma; Prognostic factor

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CTLA4 PROTEIN, HUMAN; TUMOR MARKER;

EID: 84962916545     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7421     Document Type: Article
Times cited : (80)

References (29)
  • 4
    • 16544393582 scopus 로고    scopus 로고
    • The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature
    • Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol. 2004; 22:4604-4612.
    • (2004) J Clin Oncol. , vol.22 , pp. 4604-4612
    • Langendijk, J.A.1    Leemans, C.R.2    Buter, J.3    Berkhof, J.4    Slotman, B.J.5
  • 5
    • 0028867420 scopus 로고
    • Loss of CTLA-4leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
    • Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995; 3:541-547.
    • (1995) Immunity. , vol.3 , pp. 541-547
    • Tivol, E.A.1    Borriello, F.2    Schweitzer, A.N.3    Lynch, W.P.4    Bluestone, J.A.5    Sharpe, A.H.6
  • 7
    • 0029899783 scopus 로고    scopus 로고
    • CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells
    • Krummel MF, Allison JP. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med. 1996; 183:2533-2540.
    • (1996) J Exp Med. , vol.183 , pp. 2533-2540
    • Krummel, M.F.1    Allison, J.P.2
  • 9
    • 0033062691 scopus 로고    scopus 로고
    • CD28/CTLA-4 and CD80/CD86 families: signaling and function
    • Slavik JM, Hutchcroft JE, Bierer BE. CD28/CTLA-4 and CD80/CD86 families: signaling and function. Immunol Res. 1999; 19:1-24.
    • (1999) Immunol Res. , vol.19 , pp. 1-24
    • Slavik, J.M.1    Hutchcroft, J.E.2    Bierer, B.E.3
  • 15
    • 84909967044 scopus 로고    scopus 로고
    • Epstein-Barr virus and nasopharyngeal carcinoma
    • Young LS, Dawson CW. Epstein-Barr virus and nasopharyngeal carcinoma. Chin J Cancer. 2014; 33:581-590.
    • (2014) Chin J Cancer. , vol.33 , pp. 581-590
    • Young, L.S.1    Dawson, C.W.2
  • 17
    • 84879599112 scopus 로고    scopus 로고
    • At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
    • Callahan MK, Wolchok JD. At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy. J Leukoc Biol. 2013; 94:41-53.
    • (2013) J Leukoc Biol. , vol.94 , pp. 41-53
    • Callahan, M.K.1    Wolchok, J.D.2
  • 18
    • 77249109472 scopus 로고    scopus 로고
    • Functional polymorphism of cytotoxic T-lymphocyte antigen 4 and nasopharyngeal carcinoma susceptibility in a Chinese population
    • Xiao M, Qi F, Chen X, Luo Z, Zhang L, Zheng C, Hu S, Jiang X, Zhou M, Tang J. Functional polymorphism of cytotoxic T-lymphocyte antigen 4 and nasopharyngeal carcinoma susceptibility in a Chinese population. Int J Immunogent. 2010; 37:27-32.
    • (2010) Int J Immunogent. , vol.37 , pp. 27-32
    • Xiao, M.1    Qi, F.2    Chen, X.3    Luo, Z.4    Zhang, L.5    Zheng, C.6    Hu, S.7    Jiang, X.8    Zhou, M.9    Tang, J.10
  • 20
    • 0029927713 scopus 로고    scopus 로고
    • Immunosuppression through blockade of CD28:B7-mediated costimulatory signals
    • Judge TA, Tang A, Turka LA. Immunosuppression through blockade of CD28:B7-mediated costimulatory signals. Immunol Res. 1996; 15:38-49.
    • (1996) Immunol Res. , vol.15 , pp. 38-49
    • Judge, T.A.1    Tang, A.2    Turka, L.A.3
  • 22
  • 23
    • 0035132359 scopus 로고    scopus 로고
    • Activated T lymphocytes bind in situ to stromal tissue of colon carcinoma but lack adhesion to tumor cells
    • Kruger K, Buning C, Schriever F. Activated T lymphocytes bind in situ to stromal tissue of colon carcinoma but lack adhesion to tumor cells. Eur J Immunol. 2001; 31:138-145.
    • (2001) Eur J Immunol. , vol.31 , pp. 138-145
    • Kruger, K.1    Buning, C.2    Schriever, F.3
  • 24
    • 84914176287 scopus 로고    scopus 로고
    • Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma
    • Chan KC. Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma. Chin J Cancer. 2014; 33:598-603.
    • (2014) Chin J Cancer. , vol.33 , pp. 598-603
    • Chan, K.C.1
  • 26
    • 84919767082 scopus 로고    scopus 로고
    • Diverse mechanisms regulate the surface expression of immunotherapeutic target ctla-4
    • Schneider H, Rudd CE. Diverse mechanisms regulate the surface expression of immunotherapeutic target ctla-4. Front Immunol. 2014; 5:619.
    • (2014) Front Immunol. , vol.5 , pp. 619
    • Schneider, H.1    Rudd, C.E.2
  • 28
    • 84863911486 scopus 로고    scopus 로고
    • Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study
    • Lynch TJ, Bondarenko I, Luft A, Serwatowski P, Barlesi F, Chacko R, Sebastian M, Neal J, Lu H, Cuillerot JM, Reck M. Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study. J Clin Oncol. 2012; 30:2046-2054.
    • (2012) J Clin Oncol. , vol.30 , pp. 2046-2054
    • Lynch, T.J.1    Bondarenko, I.2    Luft, A.3    Serwatowski, P.4    Barlesi, F.5    Chacko, R.6    Sebastian, M.7    Neal, J.8    Lu, H.9    Cuillerot, J.M.10    Reck, M.11
  • 29
    • 84927150740 scopus 로고    scopus 로고
    • Immune Checkpoint Blockade in Cancer Therapy
    • Postow MA, Callahan MK, Wolchok JD. Immune Checkpoint Blockade in Cancer Therapy. J Clin Oncol. 2015; 33:1974-82. doi: 10.1200/JCO.2014.59.4358.
    • (2015) J Clin Oncol. , vol.33 , pp. 1974-1982
    • Postow, M.A.1    Callahan, M.K.2    Wolchok, J.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.